MétaCan
Menu
← Back to cohort
Record W4417013955 · doi:10.1182/blood-2025-1346

Safety of prothrombin complex concentrate for emergency surgery according to the oral factor xa inhibitor level

2025· article· en· W4417013955 on OpenAlexaffabout
Ali Eshaghpour, Menaka Pai, Sam Schulman

Bibliographic record

VenueBlood · 2025
Typearticle
Languageen
FieldMedicine
TopicAtrial Fibrillation Management and Outcomes
Canadian institutionsMcMaster UniversityMcMaster University Medical Centre
FundersModernaRegeneron PharmaceuticalsSanofi
KeywordsRivaroxabanApixabanEdoxabanEmergency surgeryIncidence (geometry)Prothrombin complex concentratePROTHROMBIN COMPLEXVenous thromboembolismDabigatran

Abstract

fetched live from OpenAlex

Abstract Background: The incidence of thrombotic events after use of 4-factor prothrombin complex concentrate (4F-PCC) for oral factor Xa inhibitors-(XaI)-associated major bleeding is 3-4% and 5% in a study on 4F-PCC for XaI and emergency surgery. Rapid anti-Xa assays are seldom available, prompting clinicians to frequently administer 4F-PCC empirically. It is unknown if the thrombotic risk increases when pre-operative levels are low or unmeasured. Methods: We analyzed retrospectively all patients that received 4F-PCC between September 2018 and July 2024 at the hospitals in Hamilton, Canada, and screened for those with emergency surgery/invasive procedure as main indication. The PCC used was almost exclusively Octaplex (Octapharma). The primary outcomes were symptomatic or asymptomatic, objectively verified arterial or venous thromboembolism within 7 days from PCC infusion. The secondary outcome was the same but between day 8 and 30 postoperatively, at which timepoint other causes than preoperative PCC may be more prominent. XaI levels were determined with an anti-Xa assay, calibrated with the respective DOAC used by the patient. All-cause mortality within 30 days was also captured. The study was approved by Hamilton Integrated Research Ethics Board. Results: PCC at a median dose of 2000 units (interquartile range, 2000-2000) was administered to 224 patients on apixaban (142; 63%), rivaroxaban (71; 32%) or edoxaban (11;5%) for emergency surgery or invasive procedures. Mean age was 74 years and 42% were female. Postoperative prophylaxis against venous thromboembolism was started promptly in 184 patients (82%) after a median of 1 day (interquartile range, 1-2). Among 36 patients with high XaI levels, defined as at least 75 ng/mL there was 1 pulmonary embolism (3%); 24 patients with low levels had no events; 164 patients without any level measured had 7 events (4%) within 7 days, consisting of 5 myocardial infarctions, 1 DVT, 1 cerebral infarct. Two additional cerebral infarcts were deemed to be caused by compressive intracerebral hematomas that were evacuated. Events between day 8-30 were only in the group with no level – 3 deep vein thrombosis, 1 pulmonary embolism, 1 arterial thrombus. There were 8 deaths (22%) in the XaI high-level group, 2 (8%) in the low-level group, and 15 (9%) in the no-level group. Conclusion: The risk of thromboembolic events after 4F-PCC for management of hemostasis in patients on XaI and emergency surgery/invasive procedures appears to be similar among patients with preoperative drug levels that are high, low or not measured. These findings support the safe use of PCC in settings where rapid anti-Xa testing is unavailable.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.028
Threshold uncertainty score0.056

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.183
GPT teacher head0.375
Teacher spread0.192 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueBlood→Same topicAtrial Fibrillation Management and Outcomes→French-language works237,207→